Cargando…
P16(INK4A) is required for cisplatin resistance in cervical carcinoma SiHa cells
Cervical cancer is the third most commonly diagnosed cancer worldwide and the fourth leading cause of cancer-related mortality in females worldwide, accounting for 10–15% of cancer-related mortalities. Cytological screening and DNA testing for high-risk human papillomavirus (HPV) types have markedly...
Autores principales: | LI, YUERAN, XIAO, SONGSHU, DAN, LIU, XUE, MIN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315085/ https://www.ncbi.nlm.nih.gov/pubmed/25663864 http://dx.doi.org/10.3892/ol.2014.2814 |
Ejemplares similares
-
Reduced tumorigenicity and pathogenicity of cervical carcinoma SiHa cells selected for resistance to cidofovir
por: De Schutter, Tim, et al.
Publicado: (2013) -
Comparative In Vitro Anticancer Study
of Cisplatin Drug with Green Synthesized ZnO Nanoparticles on Cervical
Squamous Carcinoma (SiHa) Cell Lines
por: Rani, Nutan, et al.
Publicado: (2023) -
Adherence of Trichomonas vaginalis to SiHa Cells is Inhibited by Diphenyleneiodonium
por: Kim, Yeeun, et al.
Publicado: (2020) -
Hydroxychloroquine facilitates autophagosome formation but not degradation to suppress the proliferation of cervical cancer SiHa cells
por: LIU, QINGSONG, et al.
Publicado: (2014) -
Crinamine Induces Apoptosis and Inhibits Proliferation, Migration, and Angiogenesis in Cervical Cancer SiHa Cells
por: Khumkhrong, Phattharachanok, et al.
Publicado: (2019)